Co-Diagnostics (CODX) Projected to Post Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) will likely be releasing its earnings data after the market closes on Thursday, March 27th. Analysts expect Co-Diagnostics to post earnings of ($0.34) per share and revenue of $0.38 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Co-Diagnostics Trading Down 0.1 %

Shares of Co-Diagnostics stock opened at $0.46 on Wednesday. The business’s 50-day moving average price is $0.64 and its 200-day moving average price is $0.91. Co-Diagnostics has a 12 month low of $0.41 and a 12 month high of $2.23. The firm has a market capitalization of $14.78 million, a PE ratio of -0.34 and a beta of 1.29.

About Co-Diagnostics

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.